RSSTopical treatments

An Open-label, Observational Study Evaluating Desoximetasone Topical Spray 0.25% in Patients with Scalp Psoriasis

An Open-label, Observational Study Evaluating Desoximetasone Topical Spray 0.25% in Patients with Scalp Psoriasis

| May 1, 2018

by Jerry Bagel, MD, MS, and Elise Nelson, LPN, CCRC Both authors are with the Psoriasis Treatment Center of Central New Jersey in East Windsor, New Jersey. J Clin Aesthet Dermatol. 2018;11(5):27–29 Funding: This study was sponsored by Taro Pharmaceuticals U.S.A., Inc. Disclosures: The authors have no conflicts of interest relevant to the content of […]

Continue Reading

The Efficacy of a Ceramide-based Cream in Mild-to-moderate Atopic Dermatitis

The Efficacy of a Ceramide-based Cream in Mild-to-moderate Atopic Dermatitis

| May 1, 2018

by Zoe Diana Draelos, MD, and Isabelle Raymond, PhD Dr. Draelos is with Dermatology Consulting Services in High Point, North Carolina. Dr. Raymond is with Exeltis USA in Florham Park, New Jersey. J Clin Aesthet Dermatol. 2018;11(5):30–32 Funding: This study was supported by a grant from Exeltis USA. Disclosures: Dr. Draelos has no conflicts of […]

Continue Reading

Early Onset of Clinical Improvement with Ixekizumab in a Randomized, Open-label Study of Patients with Moderate-to-severe Plaque Psoriasis

Early Onset of Clinical Improvement with Ixekizumab in a Randomized, Open-label Study of Patients with Moderate-to-severe Plaque Psoriasis

| May 1, 2018

by Saakshi Khattri, MD; Orin Goldblum, MD; Kathleen Solotkin, MSN; Yasmin Amir, MD; Michelle S. Min, MD, MSci; Terri Ridenour, BSN, MBA; Fan Emily Yang, PhD; and Mark Lebwohl, MD, FAAD Dr. Khattri, Dr. Amir, Dr. Min, and Dr. Lebwohl are with the Department of Dermatology at the Icahn School of Medicine at Mount Sinai […]

Continue Reading

Efficacy, Safety, and Potency of Betamethasone Dipropionate Spray 0.05%: A Treatment for Adults with Mild-to-moderate Plaque Psoriasis

Efficacy, Safety, and Potency of Betamethasone Dipropionate Spray 0.05%: A Treatment for Adults with Mild-to-moderate Plaque Psoriasis

| April 1, 2018

by Srinivas Sidgiddi, MD, Refika I. Pakunlu, PhD, and Kent Allenby, MD Drs. Sidgiddi, Pakunlu, and Allenby are with Promius Pharma, a subsidiary of Dr. Reddy’s Laboratories, in Princeton, New Jersey. Funding: This study was funded and sponsored by the Dr. Reddy’s Laboratories group of companies in Princeton, New Jersy, USA Disclosures: Drs. Sidgiddi, Pakunlu, […]

Continue Reading